Rhythm (RYTM) Earnings Report: The Available Earnings Metric Delivers a Beat for the Current Session; Market Response: Shares Move 1.24% Up in the Latest Session - Earnings Expansion Phase
Rhythm (RYTM) Earnings Report: The Available Earnings Metric Delivers a Beat for the Current Session; Market Response: Shares Move 1.24% Up in the Latest Session - Earnings Expansion Phase dars.gov.et
Covered in this story
Analyst targets on Rhythm Pharmaceuticals Inc
- H.C. Wainwright: $90.8 → $130 by Oct 2027 · Buy via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $RYTM yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Rhythm Pharmaceuticals Inc →Summary aggregated from dars.gov.et's public RSS feed. The full reporting belongs to dars.gov.et — please read it on their site.